Compare GCT & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GCT | BCRX |
|---|---|---|
| Founded | 2019 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2022 | 1994 |
| Metric | GCT | BCRX |
|---|---|---|
| Price | $39.90 | $6.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $24.00 | $20.82 |
| AVG Volume (30 Days) | 563.4K | ★ 4.9M |
| Earning Date | 03-02-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.32 | N/A |
| EPS | ★ 3.31 | N/A |
| Revenue | ★ $1,222,932,000.00 | $599,816,000.00 |
| Revenue This Year | $9.56 | $40.20 |
| Revenue Next Year | $7.08 | $6.36 |
| P/E Ratio | $12.31 | ★ N/A |
| Revenue Growth | 10.17 | ★ 45.38 |
| 52 Week Low | $11.17 | $6.00 |
| 52 Week High | $44.71 | $11.31 |
| Indicator | GCT | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 37.34 |
| Support Level | $37.68 | $6.59 |
| Resistance Level | $41.77 | $7.15 |
| Average True Range (ATR) | 2.36 | 0.33 |
| MACD | -0.31 | -0.03 |
| Stochastic Oscillator | 29.77 | 15.76 |
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.